{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:26Z","timestamp":1753891586644,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Antipsychotics, tricyclic and 5-hydroxytryptamine reuptake inhibitors (SSRI) and 5-hydroxytryptamine and norepinephrine reuptake inhibitor (SNRI) antidepressants, and monoamine oxidase inhibitors can produce dream-rendering behaviors and\/or dystonic deregulation during REM sleep. Acute episodes are also seen with withdrawal from alcohol or sedative-hypnotics, and the use of tricyclic and SSRI antidepressants. In this article, we present a case of olanzapine treatment of a patient with cerebrovascular disease with psychobehavioural symptoms. The patient was an elderly patient who developed psychobehavioural symptoms after a sudden cerebral infarction. Initially, his symptoms improved when he took olanzapine (5\u2009mg orally once\/night). However, the patient subsequently developed symptoms of hypersomnia when he continued to take olanzapine, and the symptoms of hypersomnia gradually worsened as the dose of olanzapine was gradually increased. Benzodiazepines are often used to treat anomalous sleep, and clonazepam is one of the commonly prescribed drugs. In this case, the patient\u2019s abnormal sleep behavior was alleviated after treatment with clonazepam. As an atypical antipsychotic drug, olanzapine has been reported to cause abnormal sleep behavior during clinical use, and only one case has been reported in China. Clinicians should be aware that heteromorphic sleep can occur in patients treated with olanzapine.<\/jats:p>","DOI":"10.3389\/fneur.2023.1266204","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T15:18:47Z","timestamp":1703171927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A case report of atypical sleep in an ischemic stroke patient with psychiatric symptoms caused by olanzapine"],"prefix":"10.3389","volume":"14","author":[{"given":"Huixin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.19368\/j.cnki.2096-1782.2022.18.099","article-title":"Analysis of the efficacy, adverse reactions and quality of life scores of olanzapine in the treatment of cerebrovascular disease complicated with mental and behavioral symptoms","volume":"7","author":"Lianwang","year":"2022","journal-title":"Systems Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3969\/j.issn.1673-5110.2017.02.013","article-title":"A comparative study on the treatment of neurovascular disease with Paliperidone and olanzapine in the presence of psychiatric behavioral symptoms","volume":"20","author":"Shufang","year":"2017","journal-title":"Chin J Prac Nerv Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.7501\/j.issn.1674-6376.2018.05.027","article-title":"Analysis of curative effect of donepezil combined with olanzapine in the treatment of cerebrovascular disease with mental symptoms","volume":"41","author":"Xiaoning","year":"2018","journal-title":"Drug Eval Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ccm.2010.02.015","article-title":"The parasomnias:epidemiology, clinicalfeatures and diagnostic approach","volume":"31","author":"Avidan","year":"2010","journal-title":"Clin Chest Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","article-title":"REM sleep behaviour disorder","volume":"4","author":"Dauvilliers","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3969\/.isssn.1006-2963.2018.06,002","article-title":"Importance of clinical diagnosis and treatment of rapid eye movement sleep behavior disorder","volume":"25","author":"Guoxin","year":"2018","journal-title":"Chin J Neuroimmunol Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3969\/ji.ssn.1672-187X.2023.01.031","article-title":"One case of parasomnias induced by olanzapine","volume":"29","author":"Sanhua","year":"2023","journal-title":"J Clin Psychosom Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3969\/j.issn.1672-6731.2020.05.003","article-title":"Consensus interpretation on \"expert consensus on clinical application of tirofiban inatherosclerotic cerebrovascular disease\"","volume":"20","author":"Xiaochuan","year":"2020","journal-title":"Chin J Contemp Neurol Neurosurg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(16)00057-0","article-title":"Idiopathic rapid eyemovement sleep behaviour disorder: diagnosis, management,and the need for neuroprotective interventions","volume":"15","author":"Iranzo","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"988","DOI":"10.16153\/j.1002-7777.2020.08.021","article-title":"Comparison and analysis of causality assessment method in China and Naranjo\u2019s method in the evaluation of adverse drug reactions","volume":"34","author":"Jingjing","year":"2020","journal-title":"Chin Pharm"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition:highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration\u2014an update","volume":"14","author":"H\u00f6gl","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3867\/j.issn.1000-3002.2022.10.007","article-title":"Progress in the study of selective 5-hydroxytryptamine reuptake inhibitor combination for treatment of refractory depression","volume":"36","author":"Xiaoling","year":"2022","journal-title":"Chin J Pharmacol Toxicol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000488893","article-title":"Twenty years after: another case report of melatonin effects on REM sleep behavior disorder, using serial dopamine transporter imaging","volume":"76","author":"Kunz","year":"2017","journal-title":"Neuropsychobiology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","article-title":"Chronic behavioral disorders of human REM sleep: a new category of parasomnia","volume":"9","author":"Schenck","year":"1986","journal-title":"Sleep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1056\/NEJM199701163360306","article-title":"Melatonin in humans[J]","volume":"336","author":"Brzezinski","year":"1997","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.sleep.2012.09.018","article-title":"Treatment outcomes in REM sleep behavior disorder","volume":"14","author":"McCarter","year":"2013","journal-title":"Sleep Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8","article-title":"Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation","volume":"14","author":"Kunz","year":"1999","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1440-1819.2001.00854.x","article-title":"Melatonin therapy for REM sleep behavior disorder[J]","volume":"55","author":"Takeuchi","year":"2001","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3969\/j.issn.2096-3327.2023.05.018","article-title":"Analysis of adverse reactions to 142 psychiatric drugs","volume":"20","author":"Qiqi","year":"2023","journal-title":"Chin J Rat Drug Use"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1266204\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T15:18:59Z","timestamp":1703171939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1266204\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":20,"alternative-id":["10.3389\/fneur.2023.1266204"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1266204","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"article-number":"1266204"}}